ORCHID PHARMA Financial Statement Analysis
|
||
The Revenues of ORCHID PHARMA have increased by 19.00% YoY .
The Earnings Per Share (EPS) of ORCHID PHARMA has increased by Positive YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ORCHID PHARMA Last 5 Annual Financial Results
[BOM: 524372|NSE : ORCHPHARMA]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹666 Cr | ₹560 Cr | ₹450 Cr | ₹484 Cr | ₹600 Cr |
Expenses | ₹582 Cr | ₹505 Cr | ₹399 Cr | ₹515 Cr | ₹612 Cr |
Operating Profit (Excl OI) | ₹84 Cr | ₹55 Cr | ₹51 Cr | ₹-31 Cr | ₹-12 Cr |
Other Income | ₹19 Cr | ₹9.00 Cr | ₹15 Cr | ₹24 Cr | ₹17 Cr |
Interest | ₹33 Cr | ₹33 Cr | ₹52 Cr | ₹6.23 Cr | ₹6.69 Cr |
Depreciation | ₹55 Cr | ₹87 Cr | ₹109 Cr | ₹118 Cr | ₹130 Cr |
Profit Before Tax | ₹55 Cr | ₹-57 Cr | ₹-95 Cr | ₹-131 Cr | ₹69 Cr |
Profit After Tax | ₹55 Cr | ₹-57 Cr | ₹-95 Cr | ₹-131 Cr | ₹69 Cr |
Consolidated Net Profit | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr | ₹-131 Cr | ₹70 Cr |
Earnings Per Share (Rs) | ₹11.35 | ₹-0.48 | ₹-28.55 | ₹-32.11 | ₹7.80 |
PAT Margin (%) | 8.30 | -10.17 | -21.16 | -27.09 | 11.57 |
ROE(%) | 8.27 | -8.75 | -13.43 | -423.17 | 0.00 |
ROCE(%) | 9.11 | -2.32 | -3.53 | -6.47 | 3.08 |
Total Debt/Equity(x) | 0.48 | 0.41 | 0.69 | 0.74 | -4.59 |
Key Financials |
||
Market Cap | : | ₹ 5,287.2 Cr |
Revenue (TTM) | : | ₹ 812.2 Cr |
Net Profit(TTM) | : | ₹ 126.9 Cr |
EPS (TTM) | : | ₹ 25.0 |
P/E (TTM) | : | 41.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
ORCHID PHARMA | -3.9% | -6% | 172.7% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -7.5% | 53.9% |
CIPLA | 1.1% | -4.8% | 56.4% |
DR REDDYS LABORATORIES | 1.6% | 1.6% | 27.6% |
ZYDUS LIFESCIENCES | 5.2% | -0.2% | 90.1% |
DIVIS LABORATORIES | -1.9% | 10.7% | 21.4% |
MANKIND PHARMA | -2.3% | 0.1% | NA |
TORRENT PHARMACEUTICALS | 1.6% | 2% | 61.8% |
LUPIN | 2.4% | 2% | 132.5% |
ORCHID PHARMA Revenues
[BOM: 524372|NSE : ORCHPHARMA]
Y-o-Y | 19.00 % |
5 Yr CAGR | 2.64 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹666 Cr | 19.00 | |
Mar2022 | ₹560 Cr | 24.33 | |
Mar2021 | ₹450 Cr | -6.97 | |
Mar2020 | ₹484 Cr | -19.36 | |
Mar2019 | ₹600 Cr | - |
ORCHID PHARMA Operating Profit
[BOM: 524372|NSE : ORCHPHARMA]
Y-o-Y | 54.45 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹84 Cr | 54.45 | |
Mar2022 | ₹55 Cr | 7.73 | |
Mar2021 | ₹51 Cr | Positive | |
Mar2020 | ₹-31 Cr | Negative | |
Mar2019 | ₹-12 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 29.85 % |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 12.66% | 29.85 | |
Mar2022 | 9.75% | -13.41 | |
Mar2021 | 11.26% | Positive | |
Mar2020 | -6.45% | Negative | |
Mar2019 | -1.97% | - |
ORCHID PHARMA Profit After Tax
[BOM: 524372|NSE : ORCHPHARMA]
Y-o-Y | Positive |
5 Yr CAGR | -9.91 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹46 Cr | Positive | |
Mar2022 | ₹-1.95 Cr | Negative | |
Mar2021 | ₹-117 Cr | Negative | |
Mar2020 | ₹-131 Cr | Negative | |
Mar2019 | ₹70 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | -7.97 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 8.3 % | Positive | |
Mar2022 | -10.17 % | Negative | |
Mar2021 | -21.16 % | Negative | |
Mar2020 | -27.09 % | Negative | |
Mar2019 | 11.57 % | - |
ORCHID PHARMA Earnings Per Share (EPS)
[BOM: 524372|NSE : ORCHPHARMA]
Y-o-Y | Positive |
5 Yr CAGR | 9.83 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹11 | Positive | |
Mar2022 | ₹-0.48 | Negative | |
Mar2021 | ₹-29 | Negative | |
Mar2020 | ₹-32 | Negative | |
Mar2019 | ₹7.80 | - |
ORCHID PHARMA Return on Capital Employed (ROCE)
[BOM: 524372|NSE : ORCHPHARMA]
Y-o-Y | Positive |
5 Yr CAGR | 31.14 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 9.11% | Positive | |
Mar2022 | -2.32% | Negative | |
Mar2021 | -3.53% | Negative | |
Mar2020 | -6.47% | Negative | |
Mar2019 | 3.08% | - |
ORCHID PHARMA Share Price vs Sensex
Current Share Price | : | ₹1,042.9 |
Current MarketCap | : | ₹ 5,287.2 Cr |
Updated EOD on | : | May 03,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -3.9% |
-6% |
172.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
ORCHID PHARMA related INDICES
You may also like the below Video Courses
FAQ about ORCHID PHARMA Financials
How the annual revenues of ORCHID PHARMA have changed ?
The Revenues of ORCHID PHARMA have increased by 19.00% YoY .
How the Earnings per Share (EPS) of ORCHID PHARMA have changed?
The Earnings Per Share (EPS) of ORCHID PHARMA has increased by Positive YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs